Adma Biologics | ADMA - Loan Capital

Stock Price
15.08
Daily Change
-0.10 -0.66%
Monthly
-9.05%
Yearly
-2.33%
Q1 Forecast
15.60

Adma Biologics reported $70.08M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Adma Biologics USD 70.08M 3.32M Sep/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
BioCryst Pharmaceuticals USD 194.37M 48.43M Sep/2025
Minerva Neurosciences USD 0 86.58M Sep/2024
Novavax USD 223.63M 187K Sep/2024
Omeros USD 403.72M 27.2M Jun/2024
Takeda JPY 4.27T 81.29B Dec/2025